Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)

This study sought to evaluate the clinical impact of intraprocedural stent thrombosis (IPST), a relatively new endpoint. In the prospective, double-blind, active-controlled CHAMPION PHOENIX (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneo...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 63; no. 7; pp. 619 - 629
Main Authors GENEREUX, Philippe, STONE, Gregg W, TIEPU LIU, TODD, Meredith, SKERJANEC, Simona, HAMM, Christian W, MAHAFFEY, Kenneth W, WHITE, Harvey D, BHATT, Deepak L, HARRINGTON, Robert A, GIBSON, C. Michael, STEG, Ph. gabriel, BRENER, Sorin J, ANGIOLILLO, Dominick J, PRICE, Matthew J, PRATS, Jayne, LASALLE, Laura
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier 25.02.2014
Elsevier Limited
Subjects
WHO
PCI
Online AccessGet full text
ISSN0735-1097
1558-3597
1558-3597
DOI10.1016/j.jacc.2013.10.022

Cover

Loading…